Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,341 to 1,360 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz. | F1000Res | 2019 | 31372215 | PubTator, text mining | PubMed |
| N-Glycosylation of the Discoidin Domain Receptor Is Required for Axon Regeneration in Caenorhabditis elegans. | Genetics | 2019 | 31371405 | PubTator, text mining | PubMed |
| Discoidin domain receptor 1 deficiency in vascular smooth muscle cells leads to mislocalisation of N-cadherin contacts. | Biol Open | 2019 | 31362952 | PubTator, text mining | PubMed |
| Durable complete response in a patient with metastatic left-sided colon cancer treated with 5-fluorouracil, folinic acid, and irinotecan (FOLFIRI) and panitumumab: A case report. | Clin Case Rep | 2019 | 31360471 | PubTator, text mining | PubMed |
| Live cell measurements of interaction forces and binding kinetics between Discoidin Domain Receptor 1 (DDR1) and collagen I with atomic force microscopy. | Biochim Biophys Acta Gen Subj | 2019 | 31351093 | PubTator, text mining | PubMed |
| The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases. | Cancers (Basel) | 2019 | 31330786 | PubTator, text mining | PubMed |
| Autoimmune diseases affecting skin melanocytes in dogs, cats and horses: vitiligo and the uveodermatological syndrome: a comprehensive review. | BMC Vet Res | 2019 | 31324191 | PubTator, text mining | PubMed |
| Integrative analysis revealed potential causal genetic and epigenetic factors for multiple sclerosis. | J Neurol | 2019 | 31321514 | PubTator, text mining | PubMed |
| RhoA as a Key Regulator of Innate and Adaptive Immunity. | Cells | 2019 | 31319592 | PubTator, text mining | PubMed |
| Discoidin domain receptor 1 interactions with myosin motors contribute to collagen remodeling and tissue fibrosis. | Biochim Biophys Acta Mol Cell Res | 2019 | 31319111 | PubTator, text mining | PubMed |
| A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis. | J Exp Clin Cancer Res | 2019 | 31315643 | PubTator, text mining | PubMed |
| Arterial tissue transcriptional profiles associate with tissue remodeling and cardiovascular phenotype in children with end-stage kidney disease. | Sci Rep | 2019 | 31311999 | PubTator, text mining | PubMed |
| 2-Amino-2,3-dihydro-1H-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer Efficacy. | J Med Chem | 2019 | 31310125 | PubTator, text mining | PubMed |
| Role of Cancer-Associated Fibroblast in Gastric Cancer Progression and Resistance to Treatments. | J Oncol | 2019 | 31281359 | PubTator, text mining | PubMed |
| Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase. | J Oncol | 2019 | 31275376 | PubTator, text mining | PubMed |
| Discoidin domain receptors: A promising target in melanoma. | Pigment Cell Melanoma Res | 2019 | 31271515 | PubTator, text mining | PubMed |
| Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment. | Int J Mol Sci | 2019 | 31269742 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 1 (DDR1) tyrosine kinase is upregulated in PKD kidneys but does not play a role in the pathogenesis of polycystic kidney disease. | PLoS One | 2019 | 31260458 | PubTator, text mining | PubMed |
| Epigenetic Changes in the Pathogenesis of Rheumatoid Arthritis. | Front Genet | 2019 | 31258550 | PubTator, text mining | PubMed |
| Micro‑dimpled surface atelocollagen maintains primary human hepatocytes in culture and may promote their functionality compared with collagen coat culture. | Int J Mol Med | 2019 | 31257473 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=68